Comparison of Transanal Irrigation and Glycerol Suppositories in Treatment of Low Anterior Resection Syndrome
Recruiting now · Phase 3
Conditions studied: Low Anterior Resection Syndrome, Rectal Cancer
In brief
The study is a multicentre randomized controlled trial with the objective to compare the effect of transanal irrigation with glycerol suppositories in patients suffering from major Low Anterior Resection Syndrome (LARS).
Key facts
- Study ID
- NCT04087421
- Run by
- University of Aarhus
- People needed
- 114
- Starts
- 2019-09-17
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2023-05-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients electively treated for rectal cancer with a low anterior resection.
- Unsuccessful PCT after at least 4 weeks of treatment for LARS (LARS score >29 at evaluation).
- At least 3 months after surgery (including reversal of a temporary loop-ileostomy).
- Age >= 18 years
- Ability to understand written and spoken language actual for the including site (due to questionnaire validity).
You may not qualify if…
- Former use of TAI
- Prior systematic use of rectal emptying aids
- Anastomotic stenosis
- History of anastomotic leakage
- Current metastatic disease or local recurrence
- Ongoing oncological treatment
- Postoperative radiotherapy for rectal cancer
- Previous or current cancer in other pelvic organs than the rectum
- Underlying diarrhoeal disease
- Inflammatory bowel disease
- Dementia
- Spinal cord injury, multiple sclerosis, Parkinson's disease or other significant neurologic disease assessed to be a contributory cause to LARS symptoms.
- Inability of patient to use TAI
- Inability and unwillingness to give informed consent
- Pregnancy or intention to become pregnant during the trial period
Where it is running
- Aarhus University Hospital, Department of Surgery — Aarhus, Denmark (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.